Unexplained Sudden Death in Drug Abusers Blake Hutchinson, MS-4 Faculty Representative Gregory Davis, MD Department of Pathology.

Slides:



Advertisements
Similar presentations
Cardiac Risk In ESRD Patient
Advertisements

Karam Paul MS, MD, MBA, FACC Community Heart and Vascular.
Brugada’s Syndrome and Sudden Cardiac Death
Exercise Stress Electrocardiography
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Cardiovascular Disaster in Hemodialysis patients
SUDDEN DEATH IN VARIOUS POPULATIONS: IS GENDER A RISK FACTOR? 11 th International Symposium Heart Failure & Co Reggia di Caserta; April 29, 2011; 12:35.
Understanding Statistics in Research Articles Elizabeth Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant Professor,
Appraisal of Alcohol Withdrawal in Native Americans with the Clinical Institute Withdrawal Assessment of Alcohol Revised Scale. Paul Saladino MS, William.
Valsartan Antihypertensive Long-Term Use Evaluation Results
Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2010.
DOMENICO CORRADO, MD, PhD University of Padova, Italy
Myocardial infarction New concepts New definitions.
Clinical Trial Results. org Based on the Iron (Fe) and Atherosclerosis Study (FeAST) Leo R. Zacharski, MD; Bruce K. Chow, MS; Paula S. Howes, MS, APRN;
Journal Reading Myocardial infarction in young people Cardiol J 2009; 16, 4: 307–311 Cardiol J 2008; 15: 21–25 Presented by R 王郁菁 at ER conference.
“ Age-Related Differences in Characteristics, Performance Measures, Treatment Trends, and Outcomes in Patients with Ischemic Stroke ” Gregg C. Fonarow,
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Benefits and Risks Associated with Exercise and Exercise Testing.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Spring 2015 ETM 568 Callier, Demers, Drabek, & Hutchison Carter, E. J., Pouch, S. M., & Larson, E. L. (2014). The relationship between emergency department.
20 Cardiovascular Disease and Physical Activity chapter.
OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH CORONARY ATERY DISEASE By Ahmad Younis Professor.
Cardiac memory distinguishes between new and old left bundle branch block Alexei Shvilkin, MD, PhD.
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
A Retrospective Study of the Association of Obesity and Overweight with Admission Rate within York Hospital Emergency Department for Acute Asthma Exacerbations.
Nurse Co-ordinated Rapid Access Chest Pain Clinic
By Ameya Nerurkar Mandar Samant Chih-Pin Hsiao
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stan Schwartz MD,FACP.
Safety and feasibility of dobutamine stress cardiac magnetic resonance for cardiovascular assessment prior to renal transplantation Ripley DP 1,2, Gosling.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Silent Ischemia STABLE CAD
Acute Coronary Syndrome What is Acute Coronary Syndrome ? How can I look at an EKG and tell what part of the heart is affected ? What do ICU RNs need to.
Decreasing Incidence of Cardiogenic Shock Summary and Comment by J. Stephen Bohan, MD, MS, FACP, FACEP Published in Journal Watch Emergency Medicine December.
Risk Stratification In Patients With Chronic Myocardial Ischemia.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
Clinical Trial Results. org SAGE Trial Prakash Deedwania, MD; Peter H. Stone, MD; C. Noel Bairey Merz, MD; Juan Cosin-Aguilar, MD; Nevres Koylan, MD; Don.
Clinical Symptoms of Atrial Fibrillation according to QTc Interval Duration Kulik V.L., Yabluchansky N.I. Medical Clinics Chair National University of.
Occluded Artery Trial (OAT) Presented at The American Heart Association Scientific Session 2006 Presented by Dr. Judith S. Hochman OAT Trial.
First Author: Radu Cristina Co-Authors: Stefan Anda Tripon Florin Crauciuc George Coordinators: Banescu Claudia, MD Demian Smaranda, MD The importance.
Association of C-Reactive Protein and Acute Myocardial Infarction in HIV-Infected Patients Virginia A. Triant, MD, MPH, James B. Meigs, MD, MPH, and Steven.
Introduction Left bundle branch block (LBBB) is notorious for obscuring the ECG diagnosis of acute myocardial infarction (AMI) and, therefore, the decision.
Ordering Echocardiograms for Syncope Cost Conscious Project Marvin Chang, PGY2.
Long-term Cardiovascular Effects of 4.9 Years of Intensive Blood Pressure Control in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk.
EBM --- Journal Reading Presenter :林禹君 Date : 2005/10/26.
Prevalence of Bacteremia in Low Risk Patients with Sickle Cell Disease and Fever Shashidhar Marneni, MD Fellow(1 st Year) Pediatric Emergency Medicine.
Stumper: Too Young for Chest Pain. Stumper A 23 yo man presents to the ED with 4 hours of chest pain –Healthy Denies cigarette smoking, FHx, DM, Hypertension.
Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;
TAHAR EL KANDOUSSI, SARA ECHERKI, NAWAL DOGHMI, MOHAMED CHERTI. SEcurite de l’Echocardiographie de stress : plutôt l’effort. Cardiology B Department, Ibn.
Chemical and Radiation Threats and Hazards OVERVIEW Identification and characterization of the clinical toxicology of novel psychoactive substances (NPS)
Medical Drugs, Intoxication Substances, and Somatic Diseases Evgeniya Koshkina Deputy Director for Science Moscow Research and Practical Centre on Addictions.
Emergency Medicine Junior Teaching Programme Aberdeen Royal Infirmary Adult Syncope Evaluation in the Emergency Department Jamie Cooper Teaching 4 th March.
Tobacco Alcohol Cocaine Opioids Hallucinogens Amphetamine Marijuana No Marijuana 0 10% 20% 30% 40% 50% 60% 70% Recreational Marijuana Use & Acute Ischemic.
Indication Contraindication Preparation
Is suicide predictable? Paul St John-Smith Short Courses in Psychiatry 15/10/2008.
HYPERTENSIVE HEART DISEASE (Hypertensive cardiomyopathy)
The role of unknown risk factors in coronary heart disease
CALS Instructor Update July 14, 2016
. Troponin limit of detection plus cardiac risk stratification scores for the exclusion of myocardial infarction and 30-day adverse cardiac events in ED.
Judith H. Veis, MD, FACP Associate Director, Nephrology
Ischemic Heart Disease
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Comparative Efficiency of Exercise Stress Testing With.
Cocaine-Related Chest Pain: The Year After
Clinical need for determination of vulnerable plaques
Insights into the Importance of the Electrocardiogram in
Takotsubo Cardiomyopathy (broken heart syndrome) Domina Petric, MD
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis  Moritz C. Wyler von Ballmoos, MD, MPH, Bernhard.
ST ELEVATION Question: what causes acute myocardial infarction?
The Ottawa COPD (chronic obstructive pulmonary disease) Risk Scale (OCRS) is used in the emergency department (ED) to identify patients with acute COPD.
Presentation transcript:

Unexplained Sudden Death in Drug Abusers Blake Hutchinson, MS-4 Faculty Representative Gregory Davis, MD Department of Pathology

Key Points Cocaine causes deleterious effects on the heart Clinical toxicity from cocaine use does not correlate with blood or urine levels Even in the absence of acute cocaine intoxication, abusers are at higher risk for sudden death

Cocaine Cardiovascular Toxicity Coronary Artery Disease Coronary artery spasm 10% decrease in vessel caliber Preexisting coronary disease Accelerated atherosclerosis Supported by lab studies

Cocaine Cardiovascular Toxicity Coronary Artery Disease Coronary artery dissection Left anterior descending Hematoma compresses true lumen Intimal proliferation Resembles chronic rejection Entire length of vessel; angiography

Cocaine Cardiovascular Toxicity Myocardial Hypertrophy Clinical and autopsy studies ECG Heart weights Mechanism Cocaine induced hypertension Direct oxidant effect Direct oxidant effect

Cocaine Cardiovascular Toxicity Myocardial Hypertrophy Angiogenesis lags hypertrophy Underperfusion and ischemia Ischemia disrupts repolarization Reentry arrhythmias

Cocaine Cardiovascular Toxicity Catecholamine Toxicity Norepinephrine “myocarditis” Microfocal fibrosis Contraction band necrosis Result Favors reentry arrhythmias

Cocaine Cardiovascular Toxicity Microvascular disease Microangiopathy Cocaine induced apoptosis Thickening of small intramyocardial arteries Treatment implications Therapeutic anti-apoptotic drugs

Cocaine Cardiovascular Toxicity QT abnormalites QT interval dispersion QT in max lead – QT in min lead Increased dispersion increases chance of SCD Increased QTd in cocaine users occurs in absence of hypertrophy

Cocaine Cardiovascular Toxicity QT abnormalities Torsade de pointes Cocaine modulates ion channels Cocaine induced LQTS increases TdP risk Greater risk in partially expressed congenital LQTS and drug induced LQTS

Cocaine Clinical Toxicity Dose- response relationship Hypothesis: The severity of symptoms in patients presenting to an ED do not correlate with either blood cocaine or metabolite concentrations Blood cocaine and metabolite concentrations, and outcome of patients presenting to an ED. Blaho, et al. Am J Emerg Med 2000.

Cocaine Clinical Toxicity Dose- response relationship Methods Stimulant Intoxication Scale HR, BP, Orientation, MS, Temp Cocaine equivalents Sum of cocaine and metabolite concentration (mM)

Cocaine Clinical Toxicity Dose- response relationship Stimulant Intoxication Scale Admitted7.9 +/- 3.5 Discharged5.3 +/- 2.2 Significant difference (P = 0.008)

Cocaine Clinical Toxicity Dose- response relationship Blood cocaine levels Admitted0.33 +/ Discharged0.29 +/ No significant difference

Cocaine Clinical Toxicity Dose- response relationship Stimulant Intoxication Scale Survivor5.7+/- 2.5 Decedent12

Cocaine Clinical Toxicity Dose- response relationship Blood cocaine concentration Survivor0.27 +/ Decedent0.20 +/ No significant difference

Cocaine Clinical Toxicity Dose- response relationship Summary Neither cocaine nor metabolite concentrations were different among patients who were admitted vs discharged or who lived vs died No statistical correlation was noted between cocaine and metabolite blood concentration and SIS (r = 0.120)

Myocardial Ischemia In absence of Cocaine Hypothesis: Cocaine abusers have increased prevalence of myocardial ischemia even in the absence of cocaine on urine drug screen Myocardial Ischemia during Cocaine Withdrawal. Nademanee, et al. Annals of Internal Medicine

Myocardial Ischemia In absence of Cocaine Methods Patient population Male chronic cocaine abusers No history of heart disease Study Protocol Urine drug screen, Holter monitor, Treadmill

Myocardial Ischemia In absence of Cocaine Cocaine Abusers Normal Volunteers Total ST Changes 819 No ST changes Total2142

Myocardial Ischemia In absence of Cocaine Cocaine abusers were at higher risk for ST changes than healthy volunteers (P = , RR = 16) despite the absence of cocaine from the body and negative treadmill tests Mechanism for these changes remains unknown but coronary vasospasm is suspected

Unexplained Sudden Death Absence of established pathology Hypothesis: Deaths where neither toxicological or anatomical cause is found at autopsy share a common history of drug abuse Unexplained Sudden Death and the Likelihood of Drug Abuse. Gruszecki et al. J Forensic Sci 2005.

Unexplained Sudden Death Absence of established pathology Methods Retrospective case-control study Control group killed in MVC Study group undetermined death Matched for age and date of death Social trends Toxicological methods

Unexplained Sudden Death Absence of established pathology Methods All patients were evaluated for compelling evidence of drug abuse Decedents lacked sufficient disease to explain death, including autopsy and toxicological findings

Unexplained Sudden Death Absence of established pathology History of drug abuse Study group17 Control group1

Unexplained Sudden Death Absence of established pathology Evidence of drug abuse Study group21 Control group5 Significant difference (P = )

Unexplained Sudden Death Absence of established pathology Decedents in study group were 4.2 times (95% CI 1.6 – 11.1) more likely to have evidence of drug abuse than the control group A history of drug abuse was also present in a statistically disproportionate number of study group cases

Conclusions Evidence indicates that blood and urine concentrations of cocaine and cocaine metabolites do not correlate with severity of clinical symptoms or clinical outcomes Evidence indicates that blood and urine concentrations of cocaine and cocaine metabolites do not correlate with severity of clinical symptoms or clinical outcomes Evidence indicates that, in cases of unexplained sudden death, cocaine use plays a major role despite the lack of acute intoxication with cocaine Evidence indicates that, in cases of unexplained sudden death, cocaine use plays a major role despite the lack of acute intoxication with cocaine

Conclusions Evidence suggests that cocaine use induces chronic biochemical and physiologic changes that persist beyond the presence of cocaine in the blood Evidence suggests that cocaine use induces chronic biochemical and physiologic changes that persist beyond the presence of cocaine in the blood Evidence suggests that these changes increase the likelihood of sudden death; further research will better characterize these changes Evidence suggests that these changes increase the likelihood of sudden death; further research will better characterize these changes

References 1. Gruszecki A, McGwin G, Robinson C, Davis G. Unexplained Sudden Death and the Likelihood of Drug Abuse 2.Karch, SB: Cocaine cardiovascular toxicity. The Southern Medical Journal 2005; 98; Nademanee K, Gorelick DA, Josephson MA, Ryan MA, Wilkins JN, Robertson HA, Mody FV, Intarachot V. Myocardial ischemia during cocaine withdrawal. Ann Intern Med 1989;111:876– Blaho K, Logan B, Winbery S, Park L, Schwilke E. Blood cocaine and metabolite concentrations, clinical findings, and outcome of patients presenting to an ED. Am J Emerg Med 2000;18:593–8. 5. Stephens B, Jentzen J, Karch S, Mash D, Wetli C. Criteria for the Interpretation of Cocaine Levels in Human Biological Samples and Their Relation to the Cause of Death. Am J Forensic Med Pathol 2004;25:1-10